TCL Archive Tafinlar Subgroup Data Shows Median OS of 20 Months By Cancer History Project October 31, 2014
TCL Archive In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute By Cancer History Project October 31, 2014
TCL Archive Study: Angiopoietin-2 Levels May Predict Lenvatinib Response By Cancer History Project October 31, 2014
TCL Archive Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors By Cancer History Project October 31, 2014
TCL Archive Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study By Cancer History Project October 31, 2014
TCL Archive Zytiga and Prednisone Extends Overall Survival in mCRPC Trial By Cancer History Project October 31, 2014
TCL Archive Anamorelin Increases Body Mass In Two Global Phase III Trials By Cancer History Project October 31, 2014
TCL Archive NCI CTEP-Approved Trials For the Month of October By Cancer History Project October 31, 2014
